Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

CD8+ T Cells From HLA-B*57 Elite Suppressors Inhibit Replication of HIV-1 Escape Mutants

By Enthusiast Inc MDSeptember 29, 2014

…first stimulated with peptides corresponding to either wild type or escape variant HLA-B*5703 Gag epitopes to see if this would induce stronger suppression of replication. Intracellular cytokine staining was performed…

PROGRESS TOWARDS THE ELIMINATION OF CERVICAL CANCER AMONG WOMEN LIVING WITH HIV

By Jimmy He PharmD, DScMarch 3, 2023

…referral for treatment of invasive cervical cancers for women accessing routine HIV services. We describe cervical cancer screening and treatment results among WLHIV in PEPFAR-supported programs. Methods: PEPFAR programs in…

132 – Effect of Different Pharmacy PrEP Delivery Models on Initiation and Continuation in Kenya: A cRCT

By Jimmy He PharmD, DScMarch 31, 2026

…commodities from nearby public clinics. Co-primary outcomes were PrEP initiation and continuation (any refills), self-reported in surveys 60 days post-enrollment. Outcomes were modeled as pharmacy-level counts in Poisson generalized linear…

HIGH PREVALENCE AND ANTIBIOTIC RESISTANCE OF M GENITALIUM INFECTIONS IN MSM ON PrEP

By Enthusiast Inc MDMarch 6, 2019

…6 participants in the PEP arm (6.7%) and 4 in the no PEP arm (4.9%, p= 0.75). These infections were detected in urine (n=5), anus (n=5) or throat (n=1, combined…

MORTALITY RISK AMONG CHILDREN < 5 YEARS OLD LIVING WITH HIV ON ART

By Jimmy He PharmD, DScMarch 3, 2023

…aimed to describe and compare mortality risk among CLHIV < 5 yo on ART with that of older people living with HIV (PLHIV) ≥5 yo on ART. Methods: We analyzed…

HIGH-RESOLUTION MAPPING OF T-CELL HYBRID IMMUNITY TO THE ENTIRE SARS-CoV-2 PROTEOME

By Jimmy He PharmD, DScMarch 3, 2023

…of IFN-y T-cell responses by ELISpot assay in cryopreserved PBMCs, using a 15-mer overlapping peptide (OLP) library of 2,790 SARS-CoV-2 peptides in 100 pools. Results: We identified immunodominant T-cell responses…

486 – Consecutive Analytical Treatment Interruption Improves CD8 T-Cell Activity During Viral Control

By Jimmy He PharmD, DScApril 18, 2025

…our novel Immunoinformatics Analysis Pipeline (IMAP), we identified 33 mutationally-constrained and unique Gag-derived HIV epitopes (Gag-IMAP-peptides). The response to these peptides was determined in NC- and TC-derived CD8 T-cells by…

Preliminary Program for CROI 2022

By Scott LoveJanuary 18, 2022

…GLOBAL PrEP UPTAKE IN ADOLESCENT GIRLS AND YOUNG WOMEN – Rachel Baggaley, World Health Organization, Geneva, Switzerland EXPERIENCE WITH OFFERING PEP ALONGSIDE PrEP – James Ayieko, Kenya Medical Research Institute,…

1031 – Characteristics of N gonorrhoeae Infection in MSM: Culture Is Key but Limited Sensitivity?

By Jimmy He PharmD, DScMarch 31, 2026

…to the Microbiology Service in Amies transport medium (Deltalab©) and inoculated onto Martin-Lewis agar (Biomerieux®). NG identification was performed using the Malditof system. Susceptibility testing of isolates was carried out…

1285 – Antimicrobial Resistance of N. gonorrhoeae at a Community-Based Clinic, 2023-2024

By Jimmy He PharmD, DScMarch 20, 2025

…doxycycline as post-exposure prophylaxis (DoxyPEP) to prevent bacterial STIs. We evaluated baseline N. gonorrhoeae resistance in patients presenting to a community-based STI clinic. Methods We reviewed demographic and behavioral data…

←1
234567891011121314151617181920
…2122232425…
262728293031323334353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top